Skip to main content
Log in

Alendronic acid/pamidronic acid

Bisphosphonate-related osteonecrosis of the jaw in elderly patients: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Hong CM, Ahn B-C, Choi S-Y, Kim D-H, Lee S-W, Kwon T-G, Lee J.Implications of Three-Phase Bone Scintigraphy for the Diagnosis of Bisphosphonate-Related Osteonecrosis of the Jaw. Nuclear Medicine and Molecular Imaging 46: 162-168, No. 3, Sep 2012. Available from: URL: http://dx.doi.org/10.1007/s13139-012-0144-x - South Korea

Download references

Additional information

Key words

Alendronic-acid; adverse reactions; Elderly; drug-induced; Osteonecrosis; Pamidronic-acid

An event is serious (FDA MedWatch definition) when the patient outcome is: death; life-threatening; hospitalisation; disability; congenital anomaly; requires intervention to prevent permanent impairment or damage

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alendronic acid/pamidronic acid. React. Wkly. 1426, 7 (2012). https://doi.org/10.2165/00128415-201214260-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214260-00023

Keywords

Navigation